Inventor
BAJORATH JURGEN
DE20 patents
⚠️ This page may combine multiple inventors who share the name “BAJORATH JURGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS6090914AJul 18, 2000
CTLA4/CD28Ig hybrid fusion proteins and uses thereof
BRISTOL MYERS SQUIBB CO149 citations99
US7094874B2Aug 22, 2006
Soluble CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO86 citations97
US6051228AApr 18, 2000
Antibodies against human CD40
BRISTOL MYERS SQUIBB CO202 citations97
US7455835B2Nov 25, 2008
Methods for treating immune system diseases using a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO57 citations96
US7304033B2Dec 4, 2007
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO90 citations95
US5876950AMar 2, 1999
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
BRISTOL MYERS SQUIBB CO115 citations95
US7105166B1Sep 12, 2006
Soluble CTLA4 mutant molecules and uses thereof
BRISTOL MYERS SQUIBB CO33 citations94
US6372215B1Apr 16, 2002
Monoclonal antibodies to human CD6
BRISTOL MYERS SQUIBB CO55 citations93
US7700556B2Apr 20, 2010
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO14 citations91
US6413514B1Jul 2, 2002
Methods of using antibodies against human CD40
BRISTOL MYERS SQUIBB CO35 citations91
US7829534B2Nov 9, 2010
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO16 citations90
US7439230B2Oct 21, 2008
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO22 citations89
US9758565B2Sep 12, 2017
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO6 citations83
US7915395B2Mar 29, 2011
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
BRISTOL MYERS SQUIBB CO10 citations83
US10370428B2Aug 6, 2019
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO0 citations51